CareLit · DOI-Nachweis · Pneumologie
Pooled Safety Analysis Of Adjudicated Serious Adverse Events With The Fixed-Dose Combination Of Tiotropium + Olodaterol
DOI 10.1055/s-0036-1572050
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Köhnlein, R Buhl, K Tetzlaff, L Korducki, C Vogelmeier, L McGarvey
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Rationale: The objective of this analysis was to obtain a comprehensive and objective safety assessment of the fixed-dose combination of tiotropium with olodaterol (T+O FDC) in patients (pts) with moderate to very severe COPD. Methods: Data from two 1-year pivotal trials investigating T+O FDC 5/5 µg and T+O FDC 2.5/5 µg versus tiotropium (T) 2.5 µg, 5 µg, and olodaterol (O) 5 µg were pooled; patient narratives and p…
Zitieren
Zitierempfehlung
T Köhnlein, R Buhl, K Tetzlaff, L Korducki, C Vogelmeier, L McGarvey (2016) Pooled Safety Analysis Of Adjudicated Serious Adverse Events With The Fixed-Dose Combination Of Tiotropium + Olodaterol. Pneumologie (02). https://doi.org/10.1055/s-0036-1572050
Mit CareLit weiterarbeiten